Rory Shallis

55PUBLICATIONS
107CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsIntensive careMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Apr 09, 2026
Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Razan Mohty, Ravi Narra, Alice S Mims

|Feb 11, 2026
Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents.

Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni

|Oct 29, 2025
Feasibility, safety and outcomes of patients with newly diagnosed acute myeloid leukemia discharged 'early' after intensive induction.

Cameron J Hunter, Wei Cheng, Jan Philipp Bewersdorf

|Jun 23, 2025
Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± Durvalumab.

Jan Philipp Bewersdorf, Vanessa Hasle, Rory M Shallis

|Dec 02, 2024
Global Disparities in the Characteristics and Outcomes of Leukemia Clinical Trials: A Cross-Sectional Study of the ClinicalTrials.gov Database.

Abdulrahman Alhajahjeh, Lara K Rotter, Jessica M Stempel

|Nov 19, 2024
Cost-effectiveness of Enasidenib versus conventional care for older patients with IDH2-mutant refractory/relapsed AML.

Abdulrahman Alhajahjeh, Kishan K Patel, Rory M Shallis

Pageof 10

Frequent Collaborators

25 joint publications

Jan Phillip Bewersdorf

10 joint publications

Nikolai A Podoltsev

6 joint publications

Anand Patel

6 joint publications

Scott F Huntington